Literature & Media

​Cayman Currents Issue 35: Long COVID: Biomarker and Therapeutic Discovery

Cayman Currents


COVID-19 symptoms can persist in an estimated 10% of patients long past recovering from the worst impacts of acute infection and testing negative for SARS-CoV-2. Inconsistencies in symptoms, patient phenotypes, and risk factors make it difficult to pinpoint the exact cause of Long COVID. In this issue of Cayman Currents, explore prominent theories of underlying pathophysiology, lessons from other post-viral syndromes, and Cayman’s products and services to accelerate Long COVID research.

Article:

Download Copy (PDF)
<p>​Cayman Currents Issue 35&#58; Long COVID&#58; Biomarker and Therapeutic Discovery<br></p>
Cayman ChemicalCayman ChemicalCayman Chemical

Receive Our News & Literature Directly to Your Inbox!

Log in or register to subscribe to our email list. You will receive emails packed with new products and content that match your research interests. We only email once a week and you can unsubscribe at any time.